This document includes House Committee Amendments incorporated into the bill on Wed, Feb 13, 2019 at 10:28 AM by ngarrow.
This document includes Senate Committee Amendments incorporated into the bill on Thu, Feb 28, 2019 at 9:08 AM by estauffer.
1     
DRUG DIVERSION REPORTING REQUIREMENTS

2     
2019 GENERAL SESSION

3     
STATE OF UTAH

4     
Chief Sponsor: Steve Eliason

5     
Senate Sponsor: Curtis S. Bramble

6     

7     LONG TITLE
8     General Description:
9          This bill relates to the duty to report drug diversion.
10     Highlighted Provisions:
11          This bill:
12          ▸     defines terms; and
13          ▸     makes it a class B misdemeanor to knowingly fail to report known or suspected
14     drug diversion to law enforcement, unless reporting would violate HIPAA.
15     Money Appropriated in this Bill:
16          None
17     Other Special Clauses:
18          None
19     Utah Code Sections Affected:
20     ENACTS:
21          76-10-2203, Utah Code Annotated 1953
22     

23     Be it enacted by the Legislature of the state of Utah:
24          Section 1. Section 76-10-2203 is enacted to read:
25          76-10-2203. Duty to report drug diversion.
26          (1) As used in this section:
27          (a) "Diversion" means a practitioner's transfer of a significant amount of drugs to

28     another for an unlawful purpose.
29          (b) "Drug" means a Schedule II or Schedule III controlled substance, as defined in
30     Section 58-37-4, that is an opiate.
31          (c) "HIPAA" means the same as that term is defined in Section 26-18-17.
32          (d) "Opiate" means the same as that term is defined in Section 58-37-2.
33          (e) "Practitioner" means an individual:
34          (i) licensed, registered, or otherwise authorized by the appropriate jurisdiction to
35     administer, dispense, distribute, or prescribe a drug in the course of professional practice; or
36          (ii) employed by Ĥ→ [
an individual] a person ←Ĥ who is licensed, registered, or
36a     otherwise authorized by
37     the appropriate jurisdiction to administer, dispense, distribute, or prescribe a drug in the course
38     of professional practice Ĥ→ or standard operations ←Ĥ .
39          (f) "Significant amount" means an aggregate amount equal to, or more than, Ŝ→ [
100]
39a     500 ←Ŝ
40     morphine milligram equivalents calculated in accordance with guidelines developed by the
41     Centers for Disease Control and Prevention (CDC).
42          (2) An individual is guilty of a class B misdemeanor if the individual:
43          (a) knows Ĥ→ [
or has reason to believe] ←Ĥ that a practitioner is involved in diversion;
43a     and
44          (b) knowingly fails to report the diversion to a peace officer or law enforcement
45     agency.
46          (3) Subsection (2) does not apply to the extent that an individual is prohibited from
47     reporting by Ĥ→ 42 C.F.R. Part 2 or ←Ĥ HIPAA.